A Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study of BLU-263 in Indolent Systemic Mastocytosis
- Teh, Tse-Chieh (Primary Chief Investigator (PCI))
- Slade, Charlotte (Chief Investigator (CI))
- Bird, Robert J (Chief Investigator (CI))
- Barnes, Sara (Chief Investigator (CI))
- Kennedy, Nola (Project Manager)
Project: Research